Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches

Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches

Hepatitis B virus infection (HBV) is one of the most common causes of hepatitis, and may lead to cirrhosis or hepatocellular carcinoma. According to the World Health Organization (WHO), approximately 296 million people worldwide are carriers of the hepatitis B virus. Various nucleos(t)ide analogs, w...

Full description

Bibliographic Details
Main Authors: Rahila Zannat Sadiea, Shahnaj Sultana, Bijan Mohon Chaki, Tasnim Islam, Sharmy Dash, Sharmin Akter, Md Sayeedul Islam, Taheruzzaman Kazi, Abir Nagata, Rocco Spagnuolo, Rosellina Margherita Mancina, Md Golzar Hossain
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:International Journal of Molecular Sciences
Subjects:
hepatitis B virus
DNA replication
phytomedicines/phytochemicals
limitations
future approaches
Online Access:https://www.mdpi.com/1422-0067/23/3/1617

Similar Items

Similar Items